Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces promising surgeon feedback from the first completed cases utilizing its new CATALYSTEM Primary Hip System. Designed to address the evolving demands of primary hip surgery - including the increased adoption of anterior approach procedures – the CATALYSTEM Primary Hip System features a triple-taper stem design with uniform proximal loading.1 The reduced distal stem geometry and shorter lengths are ideal for anterior approa ...

Smith & Nephew SNATS (SNN) recently announced the launch of its TOTAL ANKLE Patient-Matched Guides. These guides are likely to provide surgeons with a predictable and efficient option to plan and perform total ankle replacement procedures. TOTAL ANKLE Patient-Matched Guides are engineered using 3D Systems' VSP surgical planning workflows and are designed to achieve a precise patient fit using fluoroscopic alignment cues and efficient instrumentation, and provide accuracy to plan. However, shares of SNN lost ...

Portra/E+ via Getty Images It takes time to turn around a large business, particularly when there are enough problems to create a 12-point to-do list, but Smith & Nephew (NYSE:SNN) is delivering on a lot of its targets and the market is taking notice. The shares have climbed over 35% since my last update, beating the broader med-tech sector, as well as peers/rivals like Stryker (SYK), Zimmer Biomet (ZBH), and Enovis (ENOV) with a combination of better than expected revenue and improving margins. It may not ...

Smith & Nephew plc (SNN) and InfuSystem Holdings, Inc. (INFU) recently announced a three-year distribution agreement for delivering Smith & Nephew's innovative RENASYS EDGE negative pressure wound therapy (NPWT) system to patients requiring home-based care for chronic wounds. The collaboration aims to enhance patient access to advanced wound care technology, leveraging InfuSystem's extensive network and service capabilities. Smith & Nephew, a global leader in medical technology, launched the RENASYS EDGE NP ...

Smith & Nephew SNATS (SNN) recently announced an exclusive digital and advanced analytics collaboration with Healthcare Outcomes Performance Company (HOPCo) – the world's largest, fully integrated, musculoskeletal value-based care and outcomes management company. The collaboration is likely to enhance solutions for Ambulatory Surgical Center's (ASC) customers, physicians, and patients through HOPCo's digital health and analytics platforms, myrecovery and Vitals. More on the Partnership Smith & Nephew is loo ...

Smith & Nephew plc (NYSE:SNN) Q2 2024 Results Conference Call August 1, 2024 2:00 AM ET Company Participants Deepak Nath - Chief Executive Officer John Rogers - Chief Financial Officer Conference Call Participants David Adlington - JD Morgan Sebastien Jantet - Panmure Liberum Richard Felton - Goldman Sachs Graham Doyle - UBS Samuel Joh - Berenberg Caitlin Cronin - Canaccord Genuity Julien Dormois - Jefferies Veronika Dubajova - Citi Robert Davies - Morgan Stanley Deepak Nath Good morning, and welcome to the ...

Core Insights - Smith+Nephew has announced an exclusive collaboration with Healthcare Outcomes Performance Company (HOPCo) to enhance digital health solutions for ambulatory surgical center (ASC) customers, physicians, and patients [1][8] - The partnership aims to integrate HOPCo's advanced analytics and digital platforms, myrecovery® and Vitals®, with Smith+Nephew's CORI Surgical System to improve surgical planning and patient outcomes [2][14] Company Overview - Smith+Nephew is a global medical technology company founded in 1856, operating in over 100 countries, and generating annual sales of $5.5 billion in 2023 [11][16] - The company focuses on the repair, regeneration, and replacement of soft and hard tissue, with a mission to restore patients' bodies and self-belief through innovative technology [16] Collaboration Details - The collaboration will leverage HOPCo's data-driven insights and analytics to enhance the capabilities of the CORI Surgical System, providing surgeons with improved analytics for personalized surgical planning and decision-making [2][14] - HOPCo's myrecovery platform will utilize patient engagement tools and provide critical quality outcome metrics, while the Vitals platform will offer analytics and dashboards to improve care coordination and efficiency [14][15] Strategic Importance - This partnership underscores Smith+Nephew's commitment to advancing orthopedic surgery through innovative technology, aiming to improve patient outcomes and transform healthcare delivery [8][15] - The integration of HOPCo's solutions is expected to unlock value in the ASC segment by utilizing remote therapeutic monitoring (RTM), patient-reported outcomes (PROMs), and analytics to drive efficiencies [8][14]

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks. One company to watch right now is Smith & Nephew SNATS (SNN) . SNN is currently sporting a Zacks Rank of #2 (Buy) and an A for Value. The stock has a Forward P/E ratio of 14.87. This compares to its industry's average Forward P/E of 20 ...

UHS' earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 8.12%. Smith & Nephew SNATS (SNN) recently announced the receipt of FDA 510(k) clearance for its new CATALYSTEM Primary Hip System. The system is made to meet the changing needs of primary hip surgery, such as the growing popularity of anterior approach procedures and the growing significance of ambulatory surgery centers. More on the CATALYSTEM System The design of CATALYSTEM facilitates accurate fit ...

Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance for its new CATALYSTEM Primary Hip System from the United States Food and Drug Administration. The system is designed to address the evolving demands of primary hip surgery including the increased adoption of anterior approach procedures and the expanding role of Ambulatory Surgery Centers (ASCs). Building on the heritage of Smith+Nephew's clinically successful stem designs,3,4 the CATAL ...